Hayden E. Klein

In a case report, dupilumab and prednisone were among the treatments for atopic dermatitis (AD) used to relieve a patient of her delayed generalized hypersensitivity reaction to the mRNA COVID-19 vaccine.

A review of 24 meta-analyses supported the need for additional monitoring of patients with diabetes and COVID-19, especially if they have comorbidities associated with diabetes.

A CDC report emphasized the need for increased investments, innovation, and focus on equity in order to end the HIV epidemic.

At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, the strategy advancement lead at Humana talked more about Humana’s health equity strategy and areas that pharmacy benefit managers (PBMs) and health plans can influence.

Telehealth provides more flexibility for patients with gastrointestinal issues to better fit their care into their lives and around symptoms they may be experiencing, said Sam Holliday, co-founder and CEO of Oshi Health.

Having at least 2 episodes of severe hypoglycemia that required hospitalization was found to be a major predictor for time to death in individuals with type 1 diabetes (T1D).

Between 2010 and 2020, pediatric antiretroviral therapy (ART) coverage tripled, but still consistently lagged behind adult ART coverage.

Pharmacists at the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting discussed the role of data collection and analysis in the movement toward health equity.

David Maahs, MD, PhD, professor of pediatrics at Stanford University and division chief of pediatric endocrinology at Lucile Packard Children’s Hospital, highlights key points from his review on pediatric diabetes technology and therapy.

Joel Segel, PhD, associate professor of health policy and administration at Penn State University, talks about what he's looking forward to as a member of The American Journal of Accountable Care's editorial board.

At the Pharmacy Quality Alliance (PQA) 2023 Annual Meeting, a patient joined a panel to give insight into the challenges of living with a chronic illness and what he sees as the pros and cons of the Inflation Reduction Act (IRA).

Panelists from Optum Life Sciences, OptumRx, and Takeda discussed the importance of collaboration in creating successful value-based agreements (VBAs) at Asembia 2023.

“As we look over the next decade, the climb is going to be steep, it's going to be challenging, but success is still possible,” said Luke Greenwalt, vice president of market access at IQVIA, during his session at Asembia 2023.

Diabetes risk perception was linked to increased TV watching and 1 less day per week of at least 60 minutes of exercise, and was not associated with nutrition or weight loss attempts among adolescents.

In a cohort of patients in New York with mpox, HIV status did not seem to affect treatment outcomes with tecovirimat, although more research is needed.

A panel at Asembia 2023 discussed what their organizations are doing to improve diversity, equity, and inclusion (DEI) at their organizations, and what others can learn from these efforts.

At the first business session of Asembia 2023, Ray Tancredi, divisional vice president at Walgreens, provided updates to the 2023 specialty therapy pipeline.

New research suggests that racial residential segregation is associated with glycemic control among Black youth with type 1 diabetes.

Researchers are beginning work on a double-blind randomized controlled trial to test the results of this preliminary study.

A recent study found that HIV is 2.5 times more common in people who use mental health services compared with the general population in South London.

At Asembia 2023, there will be a call to action for participants to adjust their current business models and advocate for access to biosimilars with lower list costs, explained Julie Reed, executive director of the Biosimilars Forum.

Although children with type 1 diabetes (T1D) are slightly more likely to experience long-term educational underachievement than their peers without T1D, those who also have a psychiatric disorder have significantly lower odds of achieving educational milestones.

In the first 2 years after receiving an HIV diagnosis, people with HIV were about 3 times more likely to develop depression, use antidepressants, and undergo electroconvulsive therapy—and 10 times more likely to commit suicide—compared with people without HIV.

HIV infection was more common among those who died of mpox compared with survivors, with an HIV prevalence of 93.9% and 38.3%, respectively, based on available information.

The risk of incident diabetes was found to be 17% greater in individuals who had COVID-19, and it was higher among men and individuals with severe COVID-19.

Research showed the risk of progression to type 1 diabetes (T1D) was nearly 70% lower among children with high iron intake compared with children with moderate iron intake.

According to interim results from the REPRIEVE study, individuals with HIV who took the daily statin experienced a 35% reduced risk of major adverse cardiovascular (CVD) events, compared with those who received a placebo.

Researchers also found correlations between contrast sensitivity function and age, HbA1c, and type 1 diabetes (T1D) duration under different lighting conditions.

A test using a single spot of dried blood successfully detected HIV, hepatitis B, and hepatitis C in all 60 samples with known amounts of each virus.

The weight loss surgery may help reverse peripheral neuropathy and improve the stability of cardiovascular autonomic neuropathy and retinopathy in individuals with class II/III obesity.